Stamford, CT and Boston, MA, April 15, 2026 (Globe Newswire) -- Beeline Medicines officially launched with $300 million in Series A financing led by Bain Capital, debuting with a portfolio of five clinical and preclinical programs in-licensed from Bristol Myers Squibb. The company's lead asset, afimetoran, is a once-daily oral TLR7/8 inhibitor for systemic lupus erythematosus currently in Phase 2, with data expected in the second half of 2026 ahead of a planned pivotal prog

Montreal and Highland Park, NJ, April 21, 2026 (Yahoo Finance) -- Modulari-T Biosciences has named Tanya E. Borsuk as its new chief executive officer. The leadership appointment is aimed at advancing the company’s strategic direction and accelerating development of its therapeutic platforms. The move positions the company to expand its pipeline and operational capabilities in the next stage of growth. Read full article here.

New York, NY, April 19, 2026 (PRNewswire) -- Pulnovo Medical closed an oversubscribed $100 million strategic financing round led by Medtronic, alongside existing investors EQT, Qiming Venture Partners, OrbiMed, Gaorong Ventures, and Lilly Asia Ventures, and new investor HSG (formerly Sequoia China). Separately, Medtronic and Pulnovo entered into a commercial agreement contemplating potential future commercialization opportunities. Read full article here.

Boston, MA, and Singapore, April 22, 2026 (Paratus) -- Paratus Sciences has appointed Alicia Secor as president and chief executive officer. The company also expanded its leadership team to strengthen operational and strategic capabilities. These changes are intended to support Paratus’ next phase of growth and advancement of its scientific programs. Read full article here.